174 related articles for article (PubMed ID: 7948013)
1. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion.
Sparks JD; Sparks CE
Biochim Biophys Acta; 1994 Nov; 1215(1-2):9-32. PubMed ID: 7948013
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
3. Assembly and secretion of hepatic very-low-density lipoprotein.
Gibbons GF
Biochem J; 1990 May; 268(1):1-13. PubMed ID: 2188646
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels are inversely correlated with the apolipoprotein B-48-containing triglyceride-rich lipoprotein production rate in insulin resistant men.
Drouin-Chartier JP; Tremblay AJ; Hogue JC; Leclerc M; Labonté MÈ; Marin J; Lamarche B; Couture P
Metabolism; 2017 Mar; 68():163-172. PubMed ID: 28183448
[TBL] [Abstract][Full Text] [Related]
6. Role of insulin in lipoprotein secretion by cultured rat hepatocytes.
Patsch W; Franz S; Schonfeld G
J Clin Invest; 1983 May; 71(5):1161-74. PubMed ID: 6343434
[TBL] [Abstract][Full Text] [Related]
7. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
Kuipers F; Jong MC; Lin Y; Eck M; Havinga R; Bloks V; Verkade HJ; Hofker MH; Moshage H; Berkel TJ; Vonk RJ; Havekes LM
J Clin Invest; 1997 Dec; 100(11):2915-22. PubMed ID: 9389759
[TBL] [Abstract][Full Text] [Related]
8. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.
Byrne CD; Wang TW; Hales CN
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):101-7. PubMed ID: 1332692
[TBL] [Abstract][Full Text] [Related]
9. Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance.
Zammit VA
Ann N Y Acad Sci; 2002 Jun; 967():52-65. PubMed ID: 12079835
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion.
Avramoglu RK; Qiu W; Adeli K
Front Biosci; 2003 Jan; 8():d464-76. PubMed ID: 12456312
[TBL] [Abstract][Full Text] [Related]
11. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism.
Topping DL; Mayes PA
Biochem J; 1972 Jan; 126(2):295-311. PubMed ID: 5071176
[TBL] [Abstract][Full Text] [Related]
12. The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism.
Carpentier A; Patterson BW; Uffelman KD; Giacca A; Vranic M; Cattral MS; Lewis GF
Diabetes; 2001 Jun; 50(6):1402-13. PubMed ID: 11375342
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state.
Lewis GF; Steiner G
Diabetes Care; 1996 Apr; 19(4):390-3. PubMed ID: 8729170
[TBL] [Abstract][Full Text] [Related]
14. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
15. Insulin-resistance and lipoprotein abnormalities.
Fruchart JC
Diabete Metab; 1991 May; 17(1 Pt 2):244-8. PubMed ID: 1936484
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the Regulation of Hepatic Metabolism by Insulin.
Titchenell PM; Lazar MA; Birnbaum MJ
Trends Endocrinol Metab; 2017 Jul; 28(7):497-505. PubMed ID: 28416361
[TBL] [Abstract][Full Text] [Related]
17. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes.
Zoltowska M; Ziv E; Delvin E; Sinnett D; Kalman R; Garofalo C; Seidman E; Levy E
Diabetes; 2003 Oct; 52(10):2539-45. PubMed ID: 14514638
[TBL] [Abstract][Full Text] [Related]
18. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes.
Vergès B
Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175
[TBL] [Abstract][Full Text] [Related]
19. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.
Matikainen N; Adiels M; Söderlund S; Stennabb S; Ahola T; Hakkarainen A; Borén J; Taskinen MR
Obesity (Silver Spring); 2014 Aug; 22(8):1854-9. PubMed ID: 24890344
[TBL] [Abstract][Full Text] [Related]
20. [Insulin and the metabolism of lipoproteins].
Romon M; Thomas-Desrousseaux P; Beuscart R; Fossati P; Sezille G; Jaillard J
Ann Endocrinol (Paris); 1983; 44(1):77-81. PubMed ID: 6347030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
